Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
M 1145Cat No. 3629 |
Price and Availability |
Biological Activity
Potent and selective galanin receptor 2 (GAL2) agonist (EC50 = 38 nM, Ki values are 6.55, 497 and 587 nM at GAL2, GAL3 and GAL1 respectively). Has an additive effect on the signal transduction of galanin.Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch
References
Runesson et al (2009) A novel GalR2-specific peptide agonist. Neuropeptides 43 187.If you know of a useful citation for this product please let us know.
Keywords: M 1145, Potent, selective, GAL2, GalR2, agonists, Receptors, Galanin
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
ATC 0065
Potent and selective MCH1 antagonist
Neuropeptide Y (scrambled)Control peptide for NPY (Cat. No. 1173).
AC 264613PAR2 receptor agonist
Kisspeptin 234KISS1/GPR54 antagonist; kisspeptin 10 analog
SF 11NPY Y2 receptor antagonist
ATC 0175 hydrochlorideMCH1 antagonist; also 5-HT2B antagonist and partial antagonist of 5-HT1A
LU AA33810Potent NPY Y5 antagonist
FPR A14FPR agonist
NPY 5RA972Potent and selective NPY Y5 antagonist
MCH (human, mouse, rat)Potent endogenous MCH agonist
SB 657510Selective urotensin-II (UT) receptor antagonist
Sign-up for new product e-alerts
RSS News Feed
Find out about new products as soon as they go live!
Click on the orange RSS button to read more about our RSS feed and actively opt in.






